Dennis M. Lanfear, President & CEO at Coherus BioSciences, Inc. (CHRS), sold 62,108 shares at $13.56 ($842K) on 2021-06-08, disclosed to the SEC on 2021-06-08.
Open-market sale of $842k CHRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.56 | 31,054 | $421K | 50.0% |
| 2 | $13.56 | 31,054 | $421K | 50.0% |
| Total | $13.56 avg | 62,108 | $842K | 100% |
| Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |
| CHRS | SELL | 2018-05-17 | $682K | — | Filing → |